MedPath
NMPA Approval

Isavuconazonium Sulfate for Injection

国药准字HJ20220054

June 16, 2022

Drug Information

注射用硫酸艾沙康唑

注射剂

200mg(按C₂₂H₁₇F₂N₅OS计)

化学药品

June 16, 2022

June 15, 2027

Company Information

Applicant Company

Level 17 151 Clarence Street Sydney NSW 2000 AUSTRALIA

Manufacturing Company

927 S. Curry Pike, 47403 Bloomington, Indiana (IN), United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用硫酸艾沙康唑 - NMPA 批准文号 | MedPath